Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Pharmaceuticals expands strategic partnership with Alvotech
Site Inspections | Teva api
Teva Pharmaceuticals Warning Letter from FDA - Parker Waichman LLP
With drugmakers clamoring, FDA looks to restart facility inspections delayed by COVID-19 | Fierce Pharma
FDA Pauses Regeneron/Teva Painkiller Study | Healthcare Packaging
TEVA Incorporates Abrasion-Resistant Adrenaline Injector Label | Healthcare Packaging
Teva, Alvotech's Humira biosimilar hit with second FDA rejection
U.S. FDA raises concerns over Teva's plant in China | Reuters
Teva wants to join Big PhRMA with an ongoing FDA Import Alert for Deficient cGMP
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva months from restarting production at Hungary plant banned by US FDA
Teva halts production at sterile injectables plant to address FDA concerns | Fierce Pharma
Teva recalls US-made drugs following contamination fears - The Boston Globe
Alvotech and Teva step up biosimilars partnership
Teva's troubled Godollo plant earns firm US FDA warning letter
FDA Inspections of Foreign Drug Manufacturers Haven't Bounced Back After Pandemic | MedPage Today
Dr. Remington Nevin - With the withdrawal of Hikma Pharmaceutical's FDA ANDA 077699, Barr Pharmaceuticals (owned by Teva) becomes the only remaining US manufacturer of generic mefloquine. https://public-inspection.federalregister.gov/2021-04520.pdf ...
Teva Stops Production At US Plant After FDA Concerns: Report
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Pharmaceuticals and Alvotech expand strategic biosimilars partnership
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
FDA Form 483 and Warning Letter, How do differ from each other? -
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
